JP2005516898A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005516898A5 JP2005516898A5 JP2003542171A JP2003542171A JP2005516898A5 JP 2005516898 A5 JP2005516898 A5 JP 2005516898A5 JP 2003542171 A JP2003542171 A JP 2003542171A JP 2003542171 A JP2003542171 A JP 2003542171A JP 2005516898 A5 JP2005516898 A5 JP 2005516898A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- acid addition
- free base
- addition salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 6
- 239000012458 free base Substances 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 206010057666 Anxiety disease Diseases 0.000 claims 1
- 206010004938 Bipolar disease Diseases 0.000 claims 1
- 206010012378 Depression Diseases 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000008024 pharmaceutical diluent Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Claims (6)
- 請求項1において定義した式Iの化合物またはその塩の製造方法であって、式II
で示される化合物を、式III
で示される化合物と反応させる工程、または式IV
で示される化合物を、式V
で示される化合物と反応させる工程、およびこのようにして得られた式Iの化合物を遊離塩基もしくは酸付加塩の形態で回収する工程を含む方法。 - 医薬として使用するための、遊離塩基または医薬上許容される酸付加塩の形態の請求項1に記載の化合物。
- うつ病、不安および双極性障害の処置における使用のための、遊離塩基または医薬上許容される酸付加塩の形態の請求項1に記載の化合物。
- 医薬担体または希釈剤とともに、遊離塩基または医薬上許容される酸付加塩の形態の請求項1に記載の化合物を含んでなる医薬組成物。
- 同時的または逐次的投与のための、治療上有効量の遊離塩基または医薬上許容される酸付加塩の形態の請求項1に記載の化合物および第二医薬物質を含んでなる組合せ剤。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0127008.1A GB0127008D0 (en) | 2001-11-09 | 2001-11-09 | Organic compounds |
PCT/EP2002/012514 WO2003040125A1 (en) | 2001-11-09 | 2002-11-08 | Piperazine derivatives having sst1 antagonistic activity |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005516898A JP2005516898A (ja) | 2005-06-09 |
JP2005516898A5 true JP2005516898A5 (ja) | 2005-12-22 |
JP4199668B2 JP4199668B2 (ja) | 2008-12-17 |
Family
ID=9925528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003542171A Expired - Fee Related JP4199668B2 (ja) | 2001-11-09 | 2002-11-08 | Sst1アンタゴニスト活性を有するピペラジン誘導体 |
Country Status (17)
Country | Link |
---|---|
US (1) | US7271168B2 (ja) |
EP (1) | EP1446399B1 (ja) |
JP (1) | JP4199668B2 (ja) |
CN (1) | CN1269811C (ja) |
AR (1) | AR037521A1 (ja) |
AT (1) | ATE294787T1 (ja) |
BR (1) | BR0213990A (ja) |
CA (1) | CA2465680A1 (ja) |
DE (1) | DE60204044T2 (ja) |
ES (1) | ES2240830T3 (ja) |
GB (1) | GB0127008D0 (ja) |
HK (1) | HK1068338A1 (ja) |
MY (1) | MY136297A (ja) |
PE (1) | PE20030539A1 (ja) |
PT (1) | PT1446399E (ja) |
TW (1) | TWI259085B (ja) |
WO (1) | WO2003040125A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7390813B1 (en) | 2001-12-21 | 2008-06-24 | Xenon Pharmaceuticals Inc. | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
CA2580844A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
AU2005286731A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
BRPI0515505A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase |
TW200626139A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
BRPI0515489A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase |
BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
BRPI0515488A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados de heterocìclicos e seu uso como agentes terapêuticos |
WO2006034312A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
WO2007130075A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
GB0514615D0 (en) | 2005-07-15 | 2005-08-24 | Novartis Ag | Organic compounds |
BRPI0922057A2 (pt) | 2008-11-19 | 2015-12-15 | Envivo Pharmaceuticals Inc | tratamento dos transtorno cognitivos com (r)-7-cloro-n-(quiniclidin-3-il)benzo[b]tiofeno-2-carboxamida e sais farmeceuticamente aceitaveis do mesmo |
RS56812B1 (sr) | 2010-05-17 | 2018-04-30 | Forum Pharmaceuticals Inc | Farmaceutske formulacije koje sadrže kristalne oblike (r)-7-hloro-n-(kinuklidin-3-il)benzo(b)tiofen-2-karboksamid hidrohlorid monohidrata |
WO2013169646A1 (en) | 2012-05-08 | 2013-11-14 | Envivo Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993001159A1 (en) * | 1991-07-10 | 1993-01-21 | Merck Sharp & Dohme Limited | Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy |
-
2001
- 2001-11-09 GB GBGB0127008.1A patent/GB0127008D0/en not_active Ceased
-
2002
- 2002-11-07 TW TW091132777A patent/TWI259085B/zh not_active IP Right Cessation
- 2002-11-07 PE PE2002001085A patent/PE20030539A1/es not_active Application Discontinuation
- 2002-11-07 AR ARP020104273A patent/AR037521A1/es not_active Application Discontinuation
- 2002-11-08 ES ES02787612T patent/ES2240830T3/es not_active Expired - Lifetime
- 2002-11-08 US US10/494,898 patent/US7271168B2/en not_active Expired - Fee Related
- 2002-11-08 CN CNB028236912A patent/CN1269811C/zh not_active Expired - Fee Related
- 2002-11-08 BR BR0213990-1A patent/BR0213990A/pt not_active Application Discontinuation
- 2002-11-08 AT AT02787612T patent/ATE294787T1/de not_active IP Right Cessation
- 2002-11-08 EP EP02787612A patent/EP1446399B1/en not_active Expired - Lifetime
- 2002-11-08 JP JP2003542171A patent/JP4199668B2/ja not_active Expired - Fee Related
- 2002-11-08 MY MYPI20024185A patent/MY136297A/en unknown
- 2002-11-08 CA CA002465680A patent/CA2465680A1/en not_active Abandoned
- 2002-11-08 DE DE60204044T patent/DE60204044T2/de not_active Expired - Lifetime
- 2002-11-08 WO PCT/EP2002/012514 patent/WO2003040125A1/en active IP Right Grant
- 2002-11-08 PT PT02787612T patent/PT1446399E/pt unknown
-
2005
- 2005-01-14 HK HK05100405A patent/HK1068338A1/xx not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005516898A5 (ja) | ||
JP2009542613A5 (ja) | ||
JP2004514663A5 (ja) | ||
JP2009507909A5 (ja) | ||
JP2013508279A5 (ja) | ||
JP2020507589A5 (ja) | ||
JP2004525178A5 (ja) | ||
JP2009523760A5 (ja) | ||
CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
JP2009536660A5 (ja) | ||
JP2003509349A5 (ja) | ||
JP2002520316A5 (ja) | ||
RU2008152763A (ru) | Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии | |
JP2009531441A5 (ja) | ||
JP2007507494A5 (ja) | ||
JP2005511697A5 (ja) | ||
JP2005530852A5 (ja) | ||
EP2308828A3 (en) | CaSR antagonist | |
JP2003503449A5 (ja) | ||
JP2006504738A5 (ja) | ||
JP2005517677A5 (ja) | ||
RU2003130644A (ru) | Производные ркарболина и их фармацевтическое применение против дипрессии и страха | |
JP2004529114A5 (ja) | ||
JP2005502636A5 (ja) | ||
JP2004523478A5 (ja) |